ASX Equity Snapshot

AFP Weekly Equity Report

AFT Pharmaceuticals Limited

Interactive chart JSON snapshot
Latest Close 3.07 AUD 12 Jun 2026
1W Return -5.5% latest completed week
4W Return 12.5% short-term follow-through
12W Return 9.6% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 2.4x vs 13-week average
Company Brief

What the company does

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New …

Snapshot

What the weekly tape is saying

AFP closed the latest completed week at 3.07 AUD. The 4-week return is 12.5% and the 12-week return is 9.6%. Trend Signal is inactive, Market Dynamics is 0.40. Setup signature: Early recovery watch with a 74/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 0.4%
Volume 2.4x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 30 Persistence of active Trend Signal over the last year and current streak.
Momentum 87 Blend of 4-week and 12-week follow-through.
Dynamics 76 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 100 Participation compared with the 13-week volume baseline.
Risk Control 54 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
3.06 AUD
Vs Trend Line
0.4%
Fair Value
2.86 AUD
Vs Fair Value
7.4%
52W High
3.37 AUD
52W Low
2.20 AUD
Drawdown
-8.9%
Range Position
74.4%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -5.5%
4W 12.5%
12W 9.6%
26W -1.6%
52W 25.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
28
52W Active Breadth
53.8%
Sector Scope
AU Healthcare
Sector Rank
100 of 146
Sector Percentile
31.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.40
4W MD Change
230.5%
Relative Strength
8.69
4W RS Change
6030.3%
Expectation
Negative
Probability
33.90%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
21.1K
13W Average
8.8K
52W Average
7.4K
Vs 13W
2.4x
Vs 52W
2.9x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.7%
52W Volatility
5.4%
Upside Weeks
22
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
5.2% / -4.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
ASX
Country
AU
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
AUD
Market Cap
337.7M

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • The latest week was a sharp negative move.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 3.07 AUD -5.5% 3.06 AUD 2.86 AUD 0.40 8.69 21.1K Off
5 Jun 2026 3.25 AUD 0.9% 3.04 AUD 2.86 AUD 0.11 17.89 5.1K On
29 May 2026 3.22 AUD 5.6% 3.03 AUD 2.86 AUD 0.01 15.89 27.5K Off
22 May 2026 3.05 AUD 11.7% 3.01 AUD 2.87 AUD -0.21 11.13 19.0K Off
15 May 2026 2.73 AUD -14.4% 3.00 AUD 2.87 AUD -0.30 0.14 10.4K Off
8 May 2026 3.19 AUD 0.0% 3.00 AUD 2.87 AUD -0.11 15.58 0 On
1 May 2026 3.19 AUD 1.3% 2.98 AUD 2.87 AUD -0.36 16.26 60 On
24 Apr 2026 3.15 AUD 0.0% 2.95 AUD 2.87 AUD -0.66 14.64 0 On
17 Apr 2026 3.15 AUD 10.5% 2.93 AUD 2.87 AUD -0.83 13.05 9.9K Off
10 Apr 2026 2.85 AUD 4.4% 2.90 AUD 2.87 AUD -1.15 2.38 2.4K Off
3 Apr 2026 2.73 AUD 0.0% 2.88 AUD 2.87 AUD -1.07 2.42 0 Off
27 Mar 2026 2.73 AUD -2.5% 2.87 AUD 2.88 AUD -0.85 3.30 12.9K On
20 Mar 2026 2.80 AUD -6.7% 2.85 AUD 2.88 AUD -0.65 7.28 6.3K On
13 Mar 2026 3.00 AUD -3.2% 2.84 AUD 2.88 AUD -0.36 12.73 4.2K On